Cargando…

Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer

BACKGROUND: Two prospective phase II trials were designed to assess the efficacy and safety of image-guided proton therapy (IGPT) for either medically inoperable or operable stage I non-small cell lung cancer (NSCLC). The present study reports the interim results of these trials. METHODS: Fifty-five...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakajima, Koichiro, Iwata, Hiromitsu, Ogino, Hiroyuki, Hattori, Yukiko, Hashimoto, Shingo, Toshito, Toshiyuki, Hayashi, Kensuke, Akita, Kenji, Baba, Fumiya, Nakamae, Katsumi, Mizoe, Jun-etsu, Shibamoto, Yuta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180633/ https://www.ncbi.nlm.nih.gov/pubmed/30305125 http://dx.doi.org/10.1186/s13014-018-1144-5

Ejemplares similares

Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia
por: Hashimoto, Shingo, et al.
Publicado: (2022)

Image-Guided Proton Therapy for Elderly Patients with Hepatocellular Carcinoma: High Local Control and Quality of Life Preservation
por: Iwata, Hiromitsu, et al.
Publicado: (2021)

Changes in sexual function and serum testosterone levels in patients with prostate cancer after image-guided proton therapy
por: Hattori, Yukiko, et al.
Publicado: (2021)

Proton therapy for non-squamous cell carcinoma of the head and neck: planning comparison and toxicity
por: Iwata, Hiromitsu, et al.
Publicado: (2019)

Whole-pelvic radiotherapy with spot-scanning proton beams for uterine cervical cancer: a planning study
por: Hashimoto, Shingo, et al.
Publicado: (2016)

Patient-Reported Quality of Life Outcomes after Moderately Hypofractionated and Normofractionated Proton Therapy for Localized Prostate Cancer
por: Nakajima, Koichiro, et al.
Publicado: (2022)

Spot Scanning Proton Therapy for Sinonasal Malignant Tumors
por: Nakajima, Koichiro, et al.
Publicado: (2021)

Combined effects of cisplatin and photon or proton irradiation in cultured cells: radiosensitization, patterns of cell death and cell cycle distribution
por: Iwata, Hiromitsu, et al.
Publicado: (2020)

Compatibility of the repairable-conditionally repairable, multi-target and linear-quadratic models in converting hypofractionated radiation doses to single doses
por: Iwata, Hiromitsu, et al.
Publicado: (2013)

Organizing pneumonia after stereotactic ablative radiotherapy of the lung
por: Murai, Taro, et al.
Publicado: (2012)

Comparison of multileaf collimator and conventional circular collimator systems in Cyberknife stereotactic radiotherapy
por: Murai, Taro, et al.
Publicado: (2017)

Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size
por: Baba, Fumiya, et al.
Publicado: (2010)

Partial-brain radiotherapy for primary central nervous system lymphoma: multi-institutional experience
por: Iwabuchi, Michio, et al.
Publicado: (2016)

The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy
por: Shibamoto, Yuta, et al.
Publicado: (2020)

Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy
por: Tatekawa, Kotoha, et al.
Publicado: (2014)

Efficacy of the Dynamic Jaw Mode in Helical Tomotherapy With Static Ports for Breast Cancer
por: Sugie, Chikao, et al.
Publicado: (2015)

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT
por: Ogawa, Yasutaka, et al.
Publicado: (2018)

Percutaneous fiducial marker placement under CT fluoroscopic guidance for stereotactic body radiotherapy of the lung: an initial experience
por: Ohta, Kengo, et al.
Publicado: (2013)

Percutaneous fiducial marker placement prior to stereotactic body radiotherapy for malignant liver tumors: an initial experience
por: Ohta, Kengo, et al.
Publicado: (2016)

Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results
por: Baba, Fumiya, et al.
Publicado: (2009)

Applicability of the linear–quadratic model to single and fractionated radiotherapy schedules: an experimental study
por: Miyakawa, Akifumi, et al.
Publicado: (2014)

Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
por: Shibamoto, Yuta, et al.
Publicado: (2016)

CyberKnife Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy As First-line Treatments for Imaging-diagnosed Intracranial Meningiomas
por: MANABE, Yoshihiko, et al.
Publicado: (2017)

Impact on dose distribution and volume changes of a bioabsorbable polyglycolic acid spacer during chemo-proton therapy for a pediatric Ewing sarcoma
por: Kimura, Mitsuhiro, et al.
Publicado: (2020)

Comparison of intensity-modulated radiotherapy with the 5-field technique, helical tomotherapy and volumetric modulated arc therapy for localized prostate cancer
por: Kita, Nozomi, et al.
Publicado: (2022)

Treatment and prognosis of patients with late rectal bleeding after intensity-modulated radiation therapy for prostate cancer
por: Takemoto, Shinya, et al.
Publicado: (2012)

Dosimetric verification of IMPT using a commercial heterogeneous phantom
por: Yasui, Keisuke, et al.
Publicado: (2019)

Long‐term outcomes of proton therapy for prostate cancer in Japan: a multi‐institutional survey of the Japanese Radiation Oncology Study Group
por: Iwata, Hiromitsu, et al.
Publicado: (2018)

Long-term multidisciplinary treatment including proton therapy for a recurrent low-grade endometrial stromal sarcoma and pathologically prominent epithelial differentiation: an autopsy case report
por: Maeda, Osamu, et al.
Publicado: (2020)

Changes in the Proliferation Rate, Clonogenicity, and Radiosensitivity of Cultured Cells During and After Continuous Low-Dose-Rate Irradiation
por: Wang, Zhen, et al.
Publicado: (2019)

Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study
por: Miyakawa, Akifumi, et al.
Publicado: (2017)

Immune-maximizing (IMAX) therapy for cancer: Combination of dendritic cell vaccine and intensity-modulated radiation
por: SHIBAMOTO, YUTA, et al.
Publicado: (2013)

Long-term results of intensity-modulated radiotherapy with three dose-fractionation regimens for localized prostate cancer
por: Takemoto, Shinya, et al.
Publicado: (2019)

Tumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report
por: Yamada, So, et al.
Publicado: (2012)

Characteristics of histologically confirmed endometriosis in cynomolgus monkeys
por: Nishimoto-Kakiuchi, A., et al.
Publicado: (2016)

Characteristics of Suspected Endometriosis without Histologic Confirmation
por: Krajisnik, A., et al.
Publicado: (2020)

Dose–volume histogram comparison between static 5-field IMRT with 18-MV X-rays and helical tomotherapy with 6-MV X-rays
por: Hayashi, Akihiro, et al.
Publicado: (2015)

Optimal timing of a γH2AX analysis to predict cellular lethal damage in cultured tumor cell lines after exposure to diagnostic and therapeutic radiation doses
por: Takano, Seiya, et al.
Publicado: (2023)

Histologically Confirmed Intracranial Tumors Managed at Enugu, Nigeria
por: Ndubuisi, Chika Anele, et al.
Publicado: (2017)

Hemoptysis due to Pulmonary Arteriovenous Malformation after Coil Embolization during Long-Term Follow-Up
por: Shimohira, Masashi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fun9iom1q7dbfv9fks3ep95asb